BioCentury
ARTICLE | Clinical News

Pivanex: Began Phase I/II testing

April 2, 2001 7:00 AM UTC

Titan Pharmaceuticals Inc. (TTP), South San Francisco, Calif. Product: Pivanex Business: Cancer Therapeutic category: Apoptosis Target: Cancer cells Description: Small molecule analog of butyric acid ...